132 related articles for article (PubMed ID: 38817208)
41. Peripheral natural killer cells exhibit qualitative and quantitative changes in patients with psoriasis and atopic dermatitis.
Luci C; Gaudy-Marqueste C; Rouzaire P; Audonnet S; Cognet C; Hennino A; Nicolas JF; Grob JJ; Tomasello E
Br J Dermatol; 2012 Apr; 166(4):789-96. PubMed ID: 22233261
[TBL] [Abstract][Full Text] [Related]
42. Role of dendritic cells in atopic dermatitis: an update.
Bieber T; Novak N; Herrmann N; Koch S
Clin Rev Allergy Immunol; 2011 Dec; 41(3):254-8. PubMed ID: 21181302
[TBL] [Abstract][Full Text] [Related]
43. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis.
Nakazato J; Kishida M; Kuroiwa R; Fujiwara J; Shimoda M; Shinomiya N
Pediatr Allergy Immunol; 2008 Nov; 19(7):605-13. PubMed ID: 18266834
[TBL] [Abstract][Full Text] [Related]
44. Insight into newly discovered innate immune modulation in atopic dermatitis.
Park CO; Noh S; Jin S; Lee NR; Lee YS; Lee H; Lee J; Lee KH
Exp Dermatol; 2013 Jan; 22(1):6-9. PubMed ID: 23088736
[TBL] [Abstract][Full Text] [Related]
45. Current Insights into Immunology and Novel Therapeutics of Atopic Dermatitis.
Kader HA; Azeem M; Jwayed SA; Al-Shehhi A; Tabassum A; Ayoub MA; Hetta HF; Waheed Y; Iratni R; Al-Dhaheri A; Muhammad K
Cells; 2021 Jun; 10(6):. PubMed ID: 34200009
[TBL] [Abstract][Full Text] [Related]
46. Neuropeptide modulation of Th1 and Th2 cytokines in peripheral blood mononuclear leucocytes in atopic dermatitis and non-atopic controls.
Gordon DJ; Ostlere LS; Holden CA
Br J Dermatol; 1997 Dec; 137(6):921-7. PubMed ID: 9470908
[TBL] [Abstract][Full Text] [Related]
47. NK cells and gamma delta+ T cells are phenotypically and functionally defective due to preferential apoptosis in patients with atopic dermatitis.
Katsuta M; Takigawa Y; Kimishima M; Inaoka M; Takahashi R; Shiohara T
J Immunol; 2006 Jun; 176(12):7736-44. PubMed ID: 16751421
[TBL] [Abstract][Full Text] [Related]
48. Vitamin A deficiency exacerbates extrinsic atopic dermatitis development by potentiating type 2 helper T cell-type inflammation and mast cell activation.
Yang H; Chen JS; Zou WJ; Tan Q; Xiao YZ; Luo XY; Gao P; Fu Z; Wang H
Clin Exp Allergy; 2020 Aug; 50(8):942-953. PubMed ID: 32559330
[TBL] [Abstract][Full Text] [Related]
49. Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial.
Simpson EL; Silverberg JI; Thyssen JP; Viguier M; Thaçi D; de Bruin-Weller M; Weidinger S; Chan G; DiBonaventura M; Biswas P; Feeney C; Koulias C; Cork MJ
Am J Clin Dermatol; 2023 Jul; 24(4):609-621. PubMed ID: 37213005
[TBL] [Abstract][Full Text] [Related]
50. Minimally invasive skin tape strip RNA sequencing identifies novel characteristics of the type 2-high atopic dermatitis disease endotype.
Dyjack N; Goleva E; Rios C; Kim BE; Bin L; Taylor P; Bronchick C; Hall CF; Richers BN; Seibold MA; Leung DYM
J Allergy Clin Immunol; 2018 Apr; 141(4):1298-1309. PubMed ID: 29309794
[TBL] [Abstract][Full Text] [Related]
51. Profile of skin barrier proteins (filaggrin, claudins 1 and 4) and Th1/Th2/Th17 cytokines in adults with atopic dermatitis.
Batista DI; Perez L; Orfali RL; Zaniboni MC; Samorano LP; Pereira NV; Sotto MN; Ishizaki AS; Oliveira LM; Sato MN; Aoki V
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1091-5. PubMed ID: 25271795
[TBL] [Abstract][Full Text] [Related]
52. Single-cell profiles reveal distinctive immune response in atopic dermatitis in contrast to psoriasis.
Zhang B; Roesner LM; Traidl S; Koeken VACM; Xu CJ; Werfel T; Li Y
Allergy; 2023 Feb; 78(2):439-453. PubMed ID: 35986602
[TBL] [Abstract][Full Text] [Related]
53. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children.
Mostafa GA; Tomoum HY; Salem SA; Abd El-Aziz MM; Abou El-Maged DI; El-Sayed El-Far I
Pediatr Allergy Immunol; 2008 Dec; 19(8):756-62. PubMed ID: 18435706
[TBL] [Abstract][Full Text] [Related]
54. A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy.
Farrell AM; Antrobus P; Simpson D; Powell S; Chapel HM; Ferry BL
Br J Dermatol; 2001 Jan; 144(1):24-33. PubMed ID: 11167679
[TBL] [Abstract][Full Text] [Related]
55. Early-onset pediatric atopic dermatitis is T
Esaki H; Brunner PM; Renert-Yuval Y; Czarnowicki T; Huynh T; Tran G; Lyon S; Rodriguez G; Immaneni S; Johnson DB; Bauer B; Fuentes-Duculan J; Zheng X; Peng X; Estrada YD; Xu H; de Guzman Strong C; Suárez-Fariñas M; Krueger JG; Paller AS; Guttman-Yassky E
J Allergy Clin Immunol; 2016 Dec; 138(6):1639-1651. PubMed ID: 27671162
[TBL] [Abstract][Full Text] [Related]
56. Deficiency in immunoglobulin G2 antibodies against staphylococcal enterotoxin C1 defines a subgroup of patients with atopic dermatitis.
Mrabet-Dahbi S; Breuer K; Klotz M; Herz U; Heeg K; Werfel T; Renz H
Clin Exp Allergy; 2005 Mar; 35(3):274-81. PubMed ID: 15784103
[TBL] [Abstract][Full Text] [Related]
57. Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic Dermatitis.
Guttman-Yassky E; Diaz A; Pavel AB; Fernandes M; Lefferdink R; Erickson T; Canter T; Rangel S; Peng X; Li R; Estrada Y; Xu H; Krueger JG; Paller AS
JAMA Dermatol; 2019 Dec; 155(12):1358-1370. PubMed ID: 31596431
[TBL] [Abstract][Full Text] [Related]
58. The immunostimulatory effect of CpG oligodeoxynucleotides on peripheral blood mononuclear cells of healthy dogs and dogs with atopic dermatitis.
Jassies-van der Lee A; Rutten V; Spiering R; van Kooten P; Willemse T; Broere F
Vet J; 2014 Apr; 200(1):103-8. PubMed ID: 24461202
[TBL] [Abstract][Full Text] [Related]
59. The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis.
Mitsuishi K; Nakamura T; Sakata Y; Yuyama N; Arima K; Sugita Y; Suto H; Izuhara K; Ogawa H
Clin Exp Allergy; 2005 Oct; 35(10):1327-33. PubMed ID: 16238792
[TBL] [Abstract][Full Text] [Related]
60. Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis.
Furukawa H; Nakamura K; Zheng X; Tojo M; Oyama N; Akiba H; Nishibu A; Kaneko F; Tsunemi Y; Saeki H; Tamaki K
J Dermatol Sci; 2004 Jun; 35(1):35-42. PubMed ID: 15194145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
